ALBO Albireo Pharma, Inc.

19.14
-1.63  -8%
Previous Close 20.77
Open 20.30
Price To book 4.19
Market Cap 120.43M
Shares 6,292,000
Volume 78,462
Short Ratio 0.94
Av. Daily Volume 23,552

SEC filingsSee all SEC filings

  1. 8-K - Current report 17866769
  2. 424B5 - Prospectus [Rule 424(b)(5)] 17866739
  3. 8-K - Current report 17863814
  4. 424B5 - Prospectus [Rule 424(b)(5)] 17863780
  5. CT ORDER - Confidential treatment order 17855783

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 planned for 2H 2017.
A4250
Progressive familial intrahepatic cholestasis (PFIC)